NPC(SH:600713) Zheng Quan Zhi Xing·2025-06-12 08:18Group 1 - The company, Nanjing Pharmaceutical Co., Ltd., has announced the issuance of its first medium-term note for 2023, with a total issuance amount of 100,000 million yuan [1] - The bond, named "23 Nanjing Pharmaceutical MTN001," has an interest rate of 3.1% and a maturity date set for June 20, 2025 [1] - The main underwriters for this bond issuance are Bank of Communications Co., Ltd. and Industrial Bank Co., Ltd. [1] Group 2 - The bond's interest and principal repayment will be managed by the China Interbank Market Clearing House Co., Ltd., which will transfer funds to bondholders on the specified payment date [1] - In case the payment date falls on a public holiday, the payment will be postponed accordingly [1] - The company and the clearing house will not be liable for any losses incurred due to delays in fund transfers if bondholders fail to notify changes in their payment account in a timely manner [1]